Welcome to our dedicated page for Clarivate Plc news (Ticker: CLVT), a resource for investors and traders seeking the latest updates and insights on Clarivate Plc stock.
Clarivate Plc (NYSE: CLVT) is described as a leading global provider of transformative intelligence, with news that reflects its activities across Academia & Government, Intellectual Property and Life Sciences & Healthcare. Company announcements frequently highlight new AI-powered tools, analytical reports and customer adoptions that illustrate how Clarivate combines enriched data, analytics and workflow software.
Recent news includes the launch of the Web of Science Research Assistant, a generative AI-powered tool that helps researchers conduct natural-language searches, perform literature reviews and explore visualizations based on more than 120 years of publication and citation data. Clarivate also reports on studies such as the Pulse of the Library report, which surveys thousands of librarians worldwide about AI adoption, open science and budget pressures, and on the annual Highly Cited Researchers list, which recognizes researchers whose work has had broad influence based on Web of Science data.
In Intellectual Property, Clarivate issues updates on solutions like IPfolio and Derwent Patent Monitor, including customer selections by organizations such as Nissan Motor Co., Ltd. and FUJIFILM Holdings Corporation. These stories emphasize how IP management platforms and AI-enabled patent review tools support more efficient IP operations and collaboration between IP and R&D teams.
Life sciences and healthcare news often centers on Clarivate analyses such as the Drugs to Watch report and Companies to Watch reports, which identify emerging therapies and innovative companies using integrated, AI-enhanced datasets. Visitors to this news page can follow Clarivate’s product launches, research reports, customer case studies and investor-related announcements to understand how the company is applying data and AI across its core markets.
Clarivate Plc (NYSE:CLVT) has unveiled its Citation Laureates™ 2024 list, recognizing 22 exceptional scientists and economists from six countries whose work is considered of Nobel stature. These individuals have made significant contributions in areas such as clean energy, nanotechnology, 3D protein structures, and quantum computing. The list includes 11 researchers from the US, six from the UK, two from Switzerland, and one each from Germany, Israel, and Japan.
Clarivate's Institute for Scientific Information (ISI)™ has successfully identified 75 Citation Laureates prior to their Nobel success. The selection process is based on publication and citation data from the Web of Science™, focusing on authors whose papers have been cited more than 2,000 times. This year's laureates span fields including Physiology or Medicine, Physics, Chemistry, and Economics.
Clarivate Plc (NYSE:CLVT) has announced the full agenda for the 15th annual Clarivate Pharmavision India conference, scheduled for September 25-26, 2024, in Ahmedabad and Hyderabad. The event focuses on improving patient outcomes and building resilience in the healthcare ecosystem. Key topics include AI in healthcare, cell and gene therapy, and market access.
The conference aims to address challenges such as healthcare affordability and access in India. Industry leaders will discuss strategies for patient-centric innovation, R&D, generics, biosimilars, and healthcare manufacturing. Notable sessions will cover topics like balancing generics and innovation, AI's role in healthcare, and addressing barriers to cell and gene therapy integration in India.
Clarivate Plc (NYSE:CLVT) has launched Primo™ Research Assistant, a generative AI-powered library discovery solution. Developed in collaboration with library partners, it offers students and researchers a seamless experience with natural language queries and immediate answers grounded in trusted sources. Key features include:
- Semantic search and natural language queries
- AI-powered answers with source references
- Search suggestions for topic expansion
- Multi-language support
The solution is built on a Retrieval Augmented Generation (RAG) architecture and utilizes the Ex Libris Central Discovery Index (CDI), containing over 5 billion records. The beta program, which began in June 2024, involved 18 institutions across 10 countries. Clarivate aims to responsibly apply AI in academia, fostering trust and innovation in research.
Clarivate Plc (NYSE:CLVT) has released its first Pulse of the Library™ report, revealing insights on Artificial Intelligence (AI) implementation in libraries. The report, based on a survey of over 1,500 librarians worldwide, shows that:
- Over 60% of libraries are evaluating or planning for AI integration
- 43% prioritize AI-powered tools for users in the next 12 months
- Key AI goals include supporting student learning (52%), research excellence (47%), and content discoverability (45%)
- 42% believe AI can automate routine tasks, freeing librarians for strategic activities
- Challenges include shrinking budgets (47%) and lack of AI expertise (32% report no training available)
The report highlights regional differences in priorities and emphasizes the need for collaboration between IT experts and senior leadership to advance AI implementation in libraries.
Clarivate Plc (NYSE: CLVT), a global leader in transformative intelligence, has announced its participation in the upcoming Goldman Sachs Communacopia + Technology Conference. Jonathan Collins, Executive Vice President and Chief Financial Officer, will represent the company at the event on Thursday, September 12, 2024, at 8:50 am Pacific Time (11:50 am Eastern Time).
Interested parties can access the live webcast of the presentation through a provided link. For those unable to attend in real-time, a replay will be available on the same platform. Additionally, the presentation will be archived on Clarivate's investor relations website for 180 days, ensuring extended access for stakeholders and interested investors.
Clarivate Plc (NYSE:CLVT) has launched the Web of Science™ Research Assistant, a generative AI-powered tool designed to enhance research efficiency. Developed in partnership with the research community, this tool leverages the Web of Science Core Collection™ to help researchers:
- Find key papers faster
- Handle complex research tasks
- Visualize connections in research fields
The Research Assistant offers flexible document searches, guided prompts, and unique data visualizations. It entered beta testing in December 2023 and was created in collaboration with librarians and researchers worldwide to ensure high standards of quality, accuracy, and privacy.
Clarivate (NYSE: CLVT), a global provider of transformative intelligence, has appointed Melanie Margolin to the expanded role of Chief Administrative and Legal Officer.
Joining the company in September 2023 as Executive Vice President and Chief Legal Officer, Margolin will now oversee human resources, facilities, communications, and brand functions, in addition to global legal affairs, risk, sustainability, privacy, and compliance.
CEO Matti Shem Tov commended Margolin for her strategic insights and emphasis on talent development, reflecting her people-centric leadership style. Margolin expressed her commitment to fostering collaboration and growth at Clarivate.
Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, has announced its participation in the Oppenheimer 27th Annual Technology, Internet & Communications Virtual Conference. Jonathan Collins, Executive Vice President and Chief Financial Officer, will present on Monday, August 12, 2024, at 2:55 pm Eastern Time.
Investors and interested parties can access the live webcast of the presentation through a provided link. A replay of the webcast will be available on Clarivate's investor relations website for 90 days following the event. This presentation offers an opportunity for stakeholders to gain insights into Clarivate's current position and future strategies in the technology and information services sector.
Clarivate Plc (NYSE: CLVT) has announced a significant leadership change. Matti Shem Tov, former CEO of ProQuest, will become the company's new CEO effective August 9, 2024, replacing Jonathan Gear. Shem Tov will also join the Board of Directors. Gear will transition to a non-executive role until November 1, 2024.
The Board and Gear mutually agreed on this transition, aiming to take Clarivate into its next phase of value creation. Under Gear's leadership, Clarivate restructured into three end-market segments, enhanced product innovation, and strengthened its balance sheet. The company is now positioned to leverage expertise within each business segment to deliver tailored solutions globally.
Shem Tov's appointment is expected to accelerate Clarivate's organic growth, leveraging his experience in product innovation and market delivery. The change comes as Clarivate reported its second quarter 2024 results.
Clarivate (NYSE: CLVT) reported its Q2 2024 financial results, showing a 2.8% revenue decrease to $650.3 million. Organic revenues dipped 0.6%, with an increase of 0.7% in subscription revenues offset by declines in re-occurring and transactional revenues.
The company posted a net loss of $304.3 million, with adjusted net income down 6.6% to $142.2 million. Adjusted diluted EPS fell 4.8% to $0.20. Adjusted EBITDA decreased by 3.7% to $274.4 million, with a margin contraction to 42.2%.
For the six months ending June 30, 2024, revenues totaled $1.27 billion, a 2% decline. Net loss for this period was $379.3 million, and adjusted net income dropped 13.2% to $245.7 million. Adjusted diluted EPS was down 12.8% to $0.34. Adjusted EBITDA was $510.7 million, a 5% decrease.
Free cash flow plummeted by $44.5 million in Q2 to $60.3 million and by $100.9 million for the first half of the year to $172.1 million.
The company reaffirmed its 2024 outlook and highlighted new product launches and positive customer responses.